<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Helicobacter pylori is a <z:mp ids='MP_0001795'>Gram-negative</z:mp> bacterium that is considered a causative agent of <z:hpo ids='HP_0004398'>peptic ulcer</z:hpo> <z:e sem="disease" ids="C0038354" disease_type="Disease or Syndrome" abbrv="">disease, gastric</z:e> <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, and gastric <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>H pylori triggers an intense leucocyte infiltration of the gastric submucosa, an action that is mediated by proinflammatory cytokines </plain></SENT>
<SENT sid="2" pm="."><plain>Because this pathogenetic mechanism is common to many other diseases, H pylori seroprevalence has also been investigated in other diseases </plain></SENT>
<SENT sid="3" pm="."><plain>H pylori seropositivity is associated with various dermatologic disorders </plain></SENT>
<SENT sid="4" pm="."><plain>Although the precise role of H pylori is unknown in these diseases, the organism can be eradicated, using simple and reliable drug regimens </plain></SENT>
<SENT sid="5" pm="."><plain>This contribution highlights the <z:e sem="disease" ids="C0037274" disease_type="Disease or Syndrome" abbrv="">dermatologic diseases</z:e> associated with H pylori seropositivity </plain></SENT>
</text></document>